Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate

scientific article published in May 2002

Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0920-9964(01)00206-7
P698PubMed publication ID11955961
P5875ResearchGate publication ID11411179

P2093author name stringErin A Hazlett
Johannes Schröder
Monte S Buchsbaum
Kenneth L Davis
Lina Shihabuddin
Jacqueline Spiegel-Cohen
Mehmet M Haznedar
Melissa B Singer
Peter Powchik
Tsechung Wei
P2860cites workCerebral glucography with positron tomography. Use in normal subjects and in patients with schizophreniaQ34274456
Frontal lobes, basal ganglia, temporal lobes--three sites for schizophrenia?Q38033509
Commentary and opinion: II. Statistical parametric mapping: ontology and current issuesQ38524504
Resting Cerebral Glucose Metabolism in First-Episode and Previously Treated Patients With Schizophrenia Relates to Clinical FeaturesQ41678618
Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenicsQ44116241
Increased temporal lobe glucose use in chronic schizophrenic patientsQ44762518
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findingsQ45181309
Striatal metabolic rate and clinical response to neuroleptics in schizophreniaQ46127995
Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning taskQ47293404
Analysis of individual positron emission tomography activation maps by detection of high signal-to-noise-ratio pixel clustersQ48291392
Brain organization in schizophreniaQ48316735
Positron emission tomography studies of abnormal glucose metabolism in schizophreniaQ48404768
Ventricular enlargement in poor-outcome schizophreniaQ48457497
D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and afterQ48471657
Cortical circumferential profile of SPECT cerebral perfusion in Alzheimer's diseaseQ48630924
Anterior cingulate gyrus volume and glucose metabolism in autistic disorderQ48652542
Progression of cerebroventricular enlargement and the subtyping of schizophreniaQ48660044
Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophreniaQ48660056
Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression--a study with single photon emission computed tomographyQ48778949
Cerebral metabolic activity correlates of subsyndromes in chronic schizophreniaQ49065206
PET and MRI of the thalamus in never-medicated patients with schizophreniaQ49158183
The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.Q52042140
Patterns of cortical activity in schizophreniaQ57266225
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patientsQ57266230
Characteristics of very poor outcome schizophreniaQ69107408
Accurate three-dimensional registration of CT, PET, and/or MR images of the brainQ69173592
Regional cerebral blood flow in patients with schizophrenia: relevance to symptom structuresQ71512367
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)25-40
P577publication date2002-05-01
P1433published inSchizophrenia ResearchQ7431607
P1476titleKraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate
P478volume55

Reverse relations

cites work (P2860)
Q35532688A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia
Q36013286A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia
Q51948610A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia.
Q37718136Clinical, Neurocognitive, Structural Imaging and Dermatogliphics in Schizophrenia According to Kraepelin Criteria.
Q46337178FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia
Q36440915Imaging phenotypes and genotypes in schizophrenia
Q52678175Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia.
Q37400450Reduction of caudate nucleus volumes in neuroleptic-naïve female subjects with schizotypal personality disorder
Q31120582Very poor outcome schizophrenia: clinical and neuroimaging aspects
Q80970946[Factors leading to bad social outcome in subjects with psychosis]

Search more.